CIK 0001479615
- Non-accelerated filer
- Smaller reporting company
Silence Therapeutics plc
Sign in to watch- Tickers
- SLN SLNCF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 2034576900
- Business address
- 12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP
Securities
- SLN American Depository Share Nasdaq
- SLNCF Common stock OTC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
Page 1 of 3 · 50 filings